Bone marrow failure: The frequency of HLA class I alleles in Japanese patients with bone marrow failure

Haematologica

Volumn 91, Issue 6, 2006, Pages 856-857

  Shichishima, Tsutomu ^a,b   Noji, Hideyoshi ^a   Ikeda, Kazuhiko ^a   Akutsu, Kazuko ^a   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Fukushima Prefectural Ohno Hospital   (Japan)

Author keywords

Aplastic anemia (AA); Bone marrow failure (BMF); HLA A*0206 allele; HLA B*4002 allele; Paroxysmal nocturnal hemoglobinuria (PNH)

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B ANTIGEN; LACTATE DEHYDROGENASE;

APLASTIC ANEMIA; ARTICLE; BONE MARROW DEPRESSION; CHROMOSOME ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; GENE FREQUENCY; GENOTYPE; HUMAN; JAPAN; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MYELODYSPLASTIC SYNDROME; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; RETICULOCYTE COUNT; BONE MARROW TRANSPLANTATION; GENETICS; IMMUNOLOGY; LETTER; TREATMENT FAILURE;

ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; GENE FREQUENCY; HEMOGLOBINURIA, PAROXYSMAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; JAPAN; TREATMENT FAILURE;

EID: 33745758590     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Young NS. The problem of clonality in aplastic anemia: Dr. Dameshek's riddle, restated. Blood 1992;79:1385-92.
2. Lee LG, Spurgeon SL, Heiner CR, Benson SC, Rosenblum BB, Menchen SM, et al. New energy transfer dyes for DNA sequencing. Nucleic Acids Res 1997;25:2816-22.
3. Shichishiroa T, Okamoto M, Ikeda K, Kaneshige T, Sugiyama H, Terasawa T, et al. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 2002;100:22-8.
4. International Agranulocytosis and Aplastic Anemia Study. Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood 1987;70:1718-21.
5. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 1991;324:1297-304.
6. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. International PNH Interest Group. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005;106:8699-709.
7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-99.
8. Saito S, Ota S, Yamada E, Inoko H, Ota M. Allele frequencies and haplotypic associations defined by allelic DNA typing of HLA class I and class loci in the Japanese population. Tissue Antigens 2000;56:522-9.
9. Maciejewski JP, Follmann D, Nakamura R, Saunthararajah Y, Rivera CE, Simonis T, et al. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood 2001;98:3513-9.